1. Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study
   Luis Paz-Ares et al, 2023, Journal of Clinical Oncology CrossRef
2. Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea
   Joo Sung Shim et al, 2024, Lung Cancer: Targets and Therapy CrossRef
3. Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices
   Lowell Hart et al, 2023, Cancer Medicine CrossRef
4. A Single-Arm Multi-Center Phase II Clinical Trial of Cadonilimab (anti-PD-1/CTLA-4) in Combination with or without Conventional Second-Line Treatment for Patients with Extensive Stage Small Cell Lung Cancer
   Can Chen et al, 2024, Technology in Cancer Research & Treatment CrossRef
5. Evaluation of Real-Life Chemoimmunotherapy Combination in Patients with Metastatic Small Cell Lung Carcinoma (SCLC): A Multicentric Case–Control Study
   Rémy Ezzedine et al, 2023, Cancers CrossRef
6. Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
   Alessio Stefani et al, 2022, Frontiers in Oncology CrossRef
7. Interaction of Camptothecin Anticancer Drugs with Ribosomal Proteins L15 and L11: A Molecular Docking Study
   Christian Bailly et al, 2023, Molecules CrossRef
8. Camptothecin and Its Derivatives from Traditional Chinese Medicine in Combination with Anticancer Therapy Regimens: A Systematic Review and Meta-Analysis
   Paul O. Odeniran et al, 2024, Cancers CrossRef
9. Misleading Reporting of a Negative Randomized Clinical Trial May Affect Clinical Practice
   Paul de Boissieu et al, 2024, Journal of Clinical Oncology CrossRef
10. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
    Apar Kishor P. Ganti et al, 2021, Journal of the National Comprehensive Cancer Network CrossRef
11. Sequential chemotherapy and icotinib as first-line treatment for advanced epidermal growth factor receptor-mutated non-small cell lung cancer
    Sheng-Jie Sun et al, 2022, World Journal of Clinical Cases CrossRef
12. Inhibition of SARS-CoV-2 Nsp9 ssDNA-Binding Activity and Cytotoxic Effects on H838, H1975, and A549 Human Non-Small Cell Lung Cancer Cells: Exploring the Potential of Nepenthes miranda Leaf Extract for Pulmonary Disease Treatment
    Hsin-Hui Su et al, 2024, International Journal of Molecular Sciences CrossRef
13. Cytotoxicity and Multi-Enzyme Inhibition of Nepenthes miranda Stem Extract on H838 Human Non-Small Cell Lung Cancer Cells and RPA32, Elastase, Tyrosinase, and Hyaluronidase Proteins
    Ching-Yi Lee et al, 2024, Plants CrossRef